Research Use Only · Not for Human Consumption 30% OFF EVERYTHING · limited time · Free Shipping on $250+ · View Lab Reports
Peptide Research Library

BPC-157

the body-protection peptide
Synthetic pentadecapeptide · also known as Body Protection Compound 157, PL 14736, Bepecin
For research use only Evidence grade C — animal data Healing / Recovery

BPC-157 is a synthetic 15-amino-acid peptide whose sequence corresponds to a fragment of “body protection compound,” a protein identified in human gastric juice.1 It has been studied extensively in rodent models for healing of tendon, ligament, muscle, bone, and gut tissue, and for effects on blood-vessel formation. Most of this evidence is preclinical — and, as with several peptides in this space, a large share comes from one research group — so the picture below is presented with those caveats.

Structure

Sequence & identity

GEPPPGKPADDAGLV
GEPPPGKPADDAGLV  ·  C₆₂H₉₈N₁₆O₂₂  ·  1419.5 g/mol
Pentadecapeptide (15 aa). Chemical identity per PubChem (CID 9941957 · InChIKey HEEWEZGQMLZMFE-RKGINYAYSA-N).5
What the research shows

Mechanisms studied

In rodent studies, researchers reported that BPC-157 accelerated healing of transected Achilles tendon and injured ligament, with improved biomechanical strength and tissue organisation versus controls.13 In tendon-fibroblast cultures it was reported to promote cell outgrowth, survival and migration, and to upregulate the growth-hormone receptor dose- and time-dependently.24 Proposed mechanisms centre on angiogenesis and cytoprotective signalling; these are preclinical findings, not established clinical effects.

Reported in studies

Dosing in the research literature

The figures below summarise regimens as reported in published research — they are not recommendations or directions for use.

Source / modelRegimen reportedNotes
Rat Achilles tendon, transection1µg/kg–ng/kg, local or systemicAccelerated healing vs control; animal model
Tendon fibroblasts, in vitro2Dose- & time-dependent in cultureCell outgrowth/migration; not a living-subject dose
Commonly cited research protocol~200–500 mcg/dayDerived from animal work; no human musculoskeletal dose-ranging data
Research use only. Peptigo products are sold to qualified researchers for laboratory use. This information summarises published research for reference and is not medical advice, a dosing recommendation, or directions for human or animal use.
Reported in studies

Effects observed in research

Across rodent models, researchers reported faster, more complete healing of tendon, ligament, muscle and gut tissue, alongside pro-angiogenic effects.13 In humans, the most-developed work is early-phase trial activity around a related preparation (PL 14736) for inflammatory bowel disease; the popular tendon and recovery uses remain unconfirmed in controlled human trials.

Honest assessment

Strength of evidence

Grade C The healing and musculoskeletal evidence is almost entirely animal and in-vitro, and a large portion originates from a single research group. Human data is limited to early-phase trials in a different indication (IBD). There are no large, blinded human trials supporting the recovery uses BPC-157 is popularly associated with.
Handling

Reconstitution & storage

Reconstitute with bacteriostatic water for laboratory handling. Store lyophilised material frozen and reconstituted material refrigerated. Use Peptigo’s reconstitution calculator and storage cheat sheet for working figures.

References

References

  1. Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976–983.
  2. Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–780.
  3. Cerovecki T, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010;28(9):1155–1161.
  4. Chang CH, et al. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066–19077.
  5. National Center for Biotechnology Information. PubChem Compound Summary: BPC-157 (CID 9941957). Chemical identity (formula, MW, InChIKey).